132 related articles for article (PubMed ID: 27507584)
21. Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies.
Novak A; Binnington B; Ngan B; Chadwick K; Fleshner N; Lingwood CA
Glycobiology; 2013 Nov; 23(11):1230-9. PubMed ID: 23906628
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy.
Furukawa J; Tsuda M; Okada K; Kimura T; Piao J; Tanaka S; Shinohara Y
PLoS One; 2015; 10(7):e0128300. PubMed ID: 26132161
[TBL] [Abstract][Full Text] [Related]
23. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry.
Hoffmann P; Hülsewig M; Duvar S; Ziehr H; Mormann M; Peter-Katalinić J; Friedrich AW; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2295-304. PubMed ID: 20623712
[TBL] [Abstract][Full Text] [Related]
24. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.
Cheung SK; Chuang PK; Huang HW; Hwang-Verslues WW; Cho CH; Yang WB; Shen CN; Hsiao M; Hsu TL; Chang CF; Wong CH
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):960-5. PubMed ID: 26677875
[TBL] [Abstract][Full Text] [Related]
25. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
26. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
27. Glycosphingolipids of human embryonic stem cells.
Breimer ME; Säljö K; Barone A; Teneberg S
Glycoconj J; 2017 Dec; 34(6):713-723. PubMed ID: 27325407
[TBL] [Abstract][Full Text] [Related]
28. Priming of macrophage by glycosphingolipids from extracellular vesicles facilitates immune tolerance for embryo-maternal crosstalk.
Lo TC; Cheng JY; Lee CW; Hung JT; Lin CC; Yeh HF; Yang BC; Huang Y; Wu HM; Yu AL; Yu J
Dev Cell; 2023 Nov; 58(22):2447-2459.e5. PubMed ID: 37989081
[TBL] [Abstract][Full Text] [Related]
29. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency.
Brimble SN; Sherrer ES; Uhl EW; Wang E; Kelly S; Merrill AH; Robins AJ; Schulz TC
Stem Cells; 2007 Jan; 25(1):54-62. PubMed ID: 17008424
[TBL] [Abstract][Full Text] [Related]
30. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
31. Chemoenzymatic Synthesis of Globo-series Glycosphingolipids and Evaluation of Their Immunosuppressive Activities.
Chiang PY; Adak AK; Liang WL; Tsai CY; Tseng HK; Cheng JY; Hwu JR; Yu AL; Hung JT; Lin CC
Chem Asian J; 2022 Aug; 17(16):e202200403. PubMed ID: 35616406
[TBL] [Abstract][Full Text] [Related]
32. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
[TBL] [Abstract][Full Text] [Related]
33. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.
Venable A; Mitalipova M; Lyons I; Jones K; Shin S; Pierce M; Stice S
BMC Dev Biol; 2005 Jul; 5():15. PubMed ID: 16033656
[TBL] [Abstract][Full Text] [Related]
34. Advanced mass spectrometry and chemical analyses reveal the presence of terminal disialyl motif on mouse B-cell glycoproteins.
Wang SH; Tsai CM; Lin KI; Khoo KH
Glycobiology; 2013 Jun; 23(6):677-89. PubMed ID: 23363740
[TBL] [Abstract][Full Text] [Related]
35. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
36. The Role of Glycosphingolipids in Immune Cell Functions.
Zhang T; de Waard AA; Wuhrer M; Spaapen RM
Front Immunol; 2019; 10():90. PubMed ID: 30761148
[TBL] [Abstract][Full Text] [Related]
37. Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation.
Wang D; Zhang T; Madunić K; de Waard AA; Blöchl C; Mayboroda OA; Griffioen M; Spaapen RM; Huber CG; Lageveen-Kammeijer GSM; Wuhrer M
J Proteome Res; 2022 Apr; 21(4):1029-1040. PubMed ID: 35168327
[TBL] [Abstract][Full Text] [Related]
38. Galectin-4 Is Involved in the Structural Changes of Glycosphingolipid Glycans in Poorly Differentiated Gastric Cancer Cells with High Metastatic Potential.
Hachisu K; Tsuchida A; Takada Y; Mizuno M; Ideo H
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569679
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients.
Pochechueva T; Alam S; Schötzau A; Chinarev A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V
J Ovarian Res; 2017 Feb; 10(1):8. PubMed ID: 28187738
[TBL] [Abstract][Full Text] [Related]
40. Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors.
Matsumoto Y; Ju T
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
